SCHEMBL1647251

SCHEMBL1647251

CC(C)COc1ccccc1-c1ccc(O)cc1C=CC(=O)CC(=O)C=Cc1ccc(O)cc1

nearest known ligand 0.60

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 18/20 0.60
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
APP P05067 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1647250 1.00 BACE1 (0.60) BACE1NFKB1NFKB2RELAAPP
SCHEMBL1645385 0.88 BACE1 (0.64) BACE1APPMAPT
SCHEMBL1645383 0.88 BACE1 (0.64) BACE1APPMAPT
SCHEMBL1648153 0.80 BACE1 (0.71) BACE1
SCHEMBL1648151 0.80 BACE1 (0.71) BACE1
SCHEMBL1645574 0.80 ERN1 (0.43) NFKB1NFKB2RELA
SCHEMBL1648281 0.76 BACE1 (1.00) BACE1
SCHEMBL1648285 0.76 BACE1 (1.00) BACE1
SCHEMBL1646430 0.76 BACE1 (0.84) BACE1
SCHEMBL1646431 0.76 BACE1 (0.84) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552220-B2 Therapeutic agent for Alzheimer's disease TOKYO INSTITUTE OF TECHNOLOGY (JP) 2013-10-08 US disclosed
EP-2305629-A1 THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE Tokyo Institute of Technology (JP) 2011-04-06 EP disclosed